Navigation Links
Voices Against Brain Cancer Comments on Recent Discovery in Ongoing Brain Cancer Research
Date:6/25/2013

New York, NY (PRWEB) June 25, 2013

On June 25, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on the recent discovery of a combination of viruses that has proven to be effective against the deadliest forms of brain tumors.

According to an article on ScienceDaily.com, a combination of the myxoma virus and the immune suppressant rapamycin can kill glioblastoma multiforme, the most common and deadliest malignant brain tumor. This was reported by research performed by the Moffitt Cancer Center.

Peter A. Forsyth, M.D., of Moffitt’s Neuro-Oncology Program, says the combination “has been shown to infect and kill both brain cancer stem cells and differentiated compartments of glioblastoma multiforme.” This finding means that current barriers to treating the disease may be overcome. For example, some brain cancer patients experience drug resistance to existing therapies, which has become an obstacle in treatment. Forsyth says, “Oncolytic viruses that infect and break down cancer cells offer promising possibilities for overcoming resistance to targeted therapies.”

The authors of the study explain that the combination of viruses have the potential to start a “multipronged attack” on a tumor, with the possibility of killing cancer cells directly through viral infection and inducing the immune system to attack the tumor. There have been several oncolytic viruses that have been tested and show promise against malignant gliomas.

Forsyth says, “We found that myxoma virus combined with rapamycin is a potentially useful combination. The idea that cancer cells can be killed by a harmless virus is an exciting prospect for therapy.”

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, sees this as a huge breakthrough for brain cancer treatment. “This discovery is obviously in its initial stages of testing but it shows promise for finding an actual cure in the somewhat near future. Any progress is good progress and we can’t commend all scientists involved in brain cancer research enough for all that they do to find an end to this deadly disease.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations
#####

Read the full story at http://www.prweb.com/releases/braincancer/research/prweb10864746.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer
2. Voices Against Brain Cancer Commends Family For Remaining Positive Despite Three Cancer Diagnoses
3. Voices Against Brain Cancer Commends Father of Nine for Running Marathons Despite Diagnosis
4. Voices Against Brain Cancer Commends Brain Cancer Survivor For His Positive Outlook
5. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
6. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
7. Voices Against Brain Cancer Commends Family for their Ongoing Efforts to Spread Brain Cancer Awareness
8. Avatar therapy helps silence voices in schizophrenia
9. Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells
10. Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle
11. Voices Against Brain Cancer Commends Mother for the Way She Honors Her Daughter’s Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be partnering with ... to schedule an appointment online in real time,” said Keith English, LocalMed CEO. “Allowing ... directory will bring more Six Month Smiles patients to their providers.” , Each month, ...
(Date:7/26/2017)... ... July 26, 2017 , ... Isodiol ... global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces ... 2017 to June 30, 2017. Iso International LLC recorded unaudited fiscal Q1 profits ...
(Date:7/26/2017)... ... 26, 2017 , ... BioPlus Specialty Pharmacy (BioPlus), ... of the HCV Treatment Path app (version 4.4.0) to keep health care providers ... All of the latest HCV medications are included in this app, including Vosevi™ ...
(Date:7/25/2017)... , ... July 25, 2017 , ... Summers in Palm ... the air conditioner — think homemade gourmet ice cream, sparkling pools, and mile-high fun. ... shop featuring fun mugs, journals, and other must-have knick knacks. Ice cream and sorbet ...
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance ... services to communities across North Carolina, is launching a charity event in conjunction ... support for the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... IBM (NYSE: IBM ) has been recognized as a ... for the fourth year in a row. 1 ... the Leaders quadrant have the highest scores for their Ability ... Leaders quadrant has the market share, credibility, and marketing and ... These vendors demonstrate a clear understanding of market needs; they ...
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. ... Corporation (NASDAQ: UTHR ) announced today that ... before the market opens on Thursday, July 27, 2017. ... host a teleconference on Thursday, July 27, 2017, at ... dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) released ... , M.D., following today,s Institute for Clinical and Economic Review,s ... on the effectiveness and value of abuse-deterrent formulations (ADF) of ... policy roundtable at the meeting. ... material cost benefit to the use of abuse-deterrent formulations (ADF) ...
Breaking Medicine Technology: